Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Myeloablative Umbilical Cord Blood Transplant for Hematologic Malignancies
NCT00305682Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Jun 2005
- Primary completion
- Dec 2019
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in hematologic malignancy, leukemia, lymphoma, myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPN), sponsored by Masonic Cancer Center. Started Jun 2005; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
hematologic malignancyleukemialymphomamyelodysplastic syndrome (MDS)myeloproliferative neoplasms (MPN)
Beyond the preview
Go deeper on NCT00305682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305682.